689 related articles for article (PubMed ID: 32882269)
1. Nanotheranostics against COVID-19: From multivalent to immune-targeted materials.
Hassanzadeh P
J Control Release; 2020 Dec; 328():112-126. PubMed ID: 32882269
[TBL] [Abstract][Full Text] [Related]
2. The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing.
Hassanzadeh P
Life Sci; 2021 Jun; 274():119289. PubMed ID: 33676931
[TBL] [Abstract][Full Text] [Related]
3. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.
Weiss C; Carriere M; Fusco L; Capua I; Regla-Nava JA; Pasquali M; Scott JA; Vitale F; Unal MA; Mattevi C; Bedognetti D; Merkoçi A; Tasciotti E; Yilmazer A; Gogotsi Y; Stellacci F; Delogu LG
ACS Nano; 2020 Jun; 14(6):6383-6406. PubMed ID: 32519842
[TBL] [Abstract][Full Text] [Related]
4. Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view.
Chatterjee S; Mishra S; Chowdhury KD; Ghosh CK; Saha KD
Life Sci; 2021 Aug; 278():119580. PubMed ID: 33991549
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations.
Rai M; Bonde S; Yadav A; Bhowmik A; Rathod S; Ingle P; Gade A
Viruses; 2021 Jun; 13(7):. PubMed ID: 34202815
[TBL] [Abstract][Full Text] [Related]
6. Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients.
Itani R; Tobaiqy M; Al Faraj A
Theranostics; 2020; 10(13):5932-5942. PubMed ID: 32483428
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology Responses to COVID-19.
Ruiz-Hitzky E; Darder M; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Del Real G; Aranda P
Adv Healthc Mater; 2020 Oct; 9(19):e2000979. PubMed ID: 32885616
[TBL] [Abstract][Full Text] [Related]
8. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
Rohilla S
Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
[TBL] [Abstract][Full Text] [Related]
9. Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges.
Rana MM
J Biomater Sci Polym Ed; 2021 Jun; 32(9):1219-1249. PubMed ID: 33787467
[TBL] [Abstract][Full Text] [Related]
10. Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic.
Bhutta ZA; Kanwal A; Ali M; Kulyar MF; Yao W; Shoaib M; Ashar A; Mahfooz A; Ijaz M; Ijaz N; Asif M; Nawaz S; Mahfooz MR; Kanwal T
Nanotechnology; 2021 Sep; 32(48):. PubMed ID: 34320471
[TBL] [Abstract][Full Text] [Related]
11. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders.
Hassanzadeh P; Atyabi F; Dinarvand R
Life Sci; 2017 Aug; 182():93-103. PubMed ID: 28583367
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology-based theranostic and prophylactic approaches against SARS-CoV-2.
Dhar A; Gupta SL; Saini P; Sinha K; Khandelwal A; Tyagi R; Singh A; Sharma P; Jaiswal RK
Immunol Res; 2024 Feb; 72(1):14-33. PubMed ID: 37682455
[TBL] [Abstract][Full Text] [Related]
13. State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2.
Derakhshan MA; Amani A; Faridi-Majidi R
ACS Appl Mater Interfaces; 2021 Apr; 13(13):14816-14843. PubMed ID: 33779135
[TBL] [Abstract][Full Text] [Related]
14. Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment.
Witika BA; Makoni PA; Mweetwa LL; Ntemi PV; Chikukwa MTR; Matafwali SK; Mwila C; Mudenda S; Katandula J; Walker RB
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339110
[TBL] [Abstract][Full Text] [Related]
15. COVID and 2020: An extraordinary year for science.
Callaway E; Ledford H; Viglione G; Watson T; Witze A
Nature; 2020 Dec; 588(7839):550-552. PubMed ID: 33318685
[No Abstract] [Full Text] [Related]
16. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
Patil AM; Göthert JR; Khairnar V
Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
[TBL] [Abstract][Full Text] [Related]
17. Can nanotechnology help in the fight against COVID-19?
Palestino G; García-Silva I; González-Ortega O; Rosales-Mendoza S
Expert Rev Anti Infect Ther; 2020 Sep; 18(9):849-864. PubMed ID: 32574081
[TBL] [Abstract][Full Text] [Related]
18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control.
Yang KC; Lin JC; Tsai HH; Hsu CY; Shih V; Hu CJ
Drug Deliv Transl Res; 2021 Aug; 11(4):1420-1437. PubMed ID: 33748879
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology versus coronavirus.
Nat Nanotechnol; 2020 Aug; 15(8):617. PubMed ID: 32764720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
